Hypermetabolic lymphadenopathy following the administration of COVID-19 vaccine and immunotherapy in a lung cancer patient: a case report

BACKGROUND: Given the current climate of the pandemic, lung cancer patients are especially vulnerable to complications from severe acute respiratory syndrome coronavirus 2 infection. As a high-risk population group, these patients are strongly advised to receive coronavirus disease 2019 vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathy, Shreya, Alvarez, Nathaniel, Jaiswal, Shubham, Williams, Ryan, Al-Khadimi, Munaf, Hackman, Sarah, Phillips, William, Kaur, Supreet, Cervantez, Sherri, Kelly, William, Taverna, Josephine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700935/
https://www.ncbi.nlm.nih.gov/pubmed/36434709
http://dx.doi.org/10.1186/s13256-022-03660-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700935/
https://www.ncbi.nlm.nih.gov/pubmed/36434709
http://dx.doi.org/10.1186/s13256-022-03660-9

Ejemplares similares